Stockscreener 앱 받기
1.21
5.22%
0.06
시간 외 거래:
1.22
0.01
+0.83%
Pacific Biosciences Of California Inc 주식(PACB)의 최신 뉴스
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SEC Filing (Aug 17, 2026) - Stock Titan
PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity - MarketBeat
ARK reports 9.59% stake in Pacific Biosciences (PACB) - Stock Titan
5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call - Yahoo Finance
Pacific Biosciences of California Inc (HAM:P09) Stock Price, Trades & News - GuruFocus
PACIFIC BIOSCIENCES (PACB) CEO granted 1.97M options and 489K RSUs - Stock Titan
Measuring – not guessing – the true path - PacBio
Weekly Recap: PACB cuts 2026 revenue guide and Mark Van Oene named CEO - TradingView
Pacific Biosciences of California, Inc. $PACB Shares Sold by Renaissance Technologies LLC - MarketBeat
Pacific Biosciences of California, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PACB) 2026-08-08 - Seeking Alpha
Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.st
Pacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen - MarketBeat
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingView
Pacific Biosciences of California, Inc. Stock 12‑Month Price Target Cut to $2.29, Implies 76% Upside - TradingView
TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3 - Moomoo
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut - Yahoo Finance
Pacific Biosciences: It's Only Getting Worse (NASDAQ:PACB) - Seeking Alpha
Pacific Biosciences of California Q2 Earnings Call Highlights - TradingView
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Pacific Biosciences of California Appoints New CEO, Plans to Cut 8% of Workforce - Moomoo
Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
PacBio Q2 2026 slides: SPRQ-Nx launch amid revenue miss, cut guidance - Investing.com
Is Pacific Biosciences (PACB) Positioned for Growth After Q2 Ear - GuruFocus
PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings - Barchart.com
Pacific Biosciences of CaliforniaEstimates - Moomoo
PacBio names Mark Van Oene as CEO, replacing Christian Henry By Investing.com - Investing.com South Africa
PACIFIC BIOSCIENCES OF CALIFORNIACHRISTIAN HENRY STEPS DOWN AS PRESIDENT AND CEO - Moomoo
PacBio Appoints Mark Van Oene as President and Chief Executive Officer - The Manila Times
Pacbio Appoints Mark Van Oene as President an - Moomoo
Pacific Biosciences Announces Restructuring Plan, Cutting 8% of Workforce to Drive Up to $40 Million in Annual Savings by 2027 - marketscreener.com
PacBio Announces Second Quarter 2026 Financial Results - The Manila Times
Press Release: PacBio Appoints Mark Van Oene as President and Chief Executive Officer - Moomoo
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Full Year of 2026 - marketscreener.com
PacBio Vega adds two- and four-hour runs for short-insert DNA - Stock Titan
Pacific Biosciences of California, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect - barchart.com
Pacific Biosciences of California Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
PACB5949325 Bond Profile — Key Metrics - TradingView
PACB5949325 Bond Risk Profile - TradingView
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference - GlobeNewswire
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pacific Biosciences of California Inc (PACB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pacific Biosciences of California, Inc. Revenue Breakdown – NASDAQ:PACB - TradingView
PACB|Pacific Biosciences of California Inc|Price:1.360|Chg%:-0.040 - TradingKey
Pacific Biosciences of California Inc (PACB) Institutional Confidence - TradingKey
Pacific Biosciences of California Inc - TradingKey
Pacific Biosciences of California (PACB) to Post Quarterly Earnings on Monday - MarketBeat
Pacific Biosciences of California Inc (PACB) Cash Flow - TradingKey
PACB|Pacific Biosciences of California Inc|Price:1.360| - TradingKey
Pacific Biosciences of California Inc (PACB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pacific Biosciences of California Inc (PACB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pacific Biosciences of California Inc (PACB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PACB stock reflects Illumina merger plan as investors weigh 2025 revenue outlook - Ad-hoc-news.de
Pacific Biosciences of California offers expert guidance for targeted sequencing applications - Traders Union
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market - Yahoo Finance
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 - Moomoo
PacBio’s next earnings update will stream live Aug. 5 - Stock Titan
2.43%
자본화:
|
볼륨(24시간):